Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Palozest 0.25mg Injection
Manufacturer/Marketed By : ZEE LABORATORIES LTD
$2.50 $1.51
Sidmex Inovia offers bulk export supply of Palozest 0.25mg Injection (PALONOSETRON) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
PALONOSETRON
Active Pharmaceutical Ingredient
Palozest 0.25mg Injection
$2.50
$1.51
Sidmex Inovia offers bulk export supply of Palozest 0.25mg Injection (PALONOSETRON) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Palozest 0.25mg Injection is an antiemetic drug belonging to the class of 5-HT3 receptor antagonists, containing the active ingredient Palonosetron. It is used to prevent and treat nausea, vomiting, or sickness caused by cancer treatments such as chemotherapy, radiotherapy, or after surgery. Nausea is characterised by stomach pain and the urge to vomit. The forcible voluntary or involuntary emptying of the stomach's contents through the mouth is known as vomiting. The common side effects that are likely to occur with this medicine are hives, swollen face, breathing trouble and chest pain. Inform your healthcare provider if these side effects concern you or persist for longer than usual. It is given right away or later with anticancer medicines. It is usually given up to 24 hours while recovering from anaesthesia after surgery. Talk to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals in your blood (such as magnesium and potassium). This medicine should not be used if you are allergic to Palozest 0.25mg Injection. Tell your physician about all the medications you are taking recently, including herbal medicines and supplements, before taking Palonosetron.
Active Pharmaceutical Ingredient
Uses
• Postoperative nausea and vomiting.
• Chemotherapy induced nausea and vomiting.
Benefits
Palonosetron is an Isoquinoline derivative that interacts with 5-HT3 receptor antagonists. It is a type of serotonin receptor antagonist, which works by blocking the action of serotonin in the body that induces nausea and vomiting. They are also effective in the prevention and treatment of nausea and vomiting in patients undergoing radiation therapy to the whole body or abdomen.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Allergic reactions
• Hives
• Swollen face
• Breathing trouble
• Chest pain
Common Side Effects
• Headache
• Fatigue
• Dizziness
• Abdominal pain.
How To Use
The medicine will be administered to you by a qualified healthcare professional in a hospital setting. This injection will be given intravenously into a vein in your arm or hand. Do not self-administer this medicine. The dose of the injection will be decided by your doctor based on your disease condition and other factors. Palozest 0.25mg Injection is usually given about 30 minutes before you receive your anti-cancer medicine (chemotherapy) or right before anaesthesia for surgery. If you are taking palonosetron as an oral tablet, it should be swallowed whole with a glass of water, with or without food, as directed by your healthcare provider. Do not crush, chew, or break the tablet before swallowing it.
Safety Advice
• Breast Feeding: It is unsafe to breastfeed during the treatment with this injection because it may cause harm to the baby. Please consult your doctor before breastfeeding.
• Alcohol: It is unknown whether consuming alcohol interacts with Palozest 0.25mg Injection. Please consult your doctor for more advice.
• Liver: It is unknown whether Palozest 0.25mg Injection can be administered to patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with Palonosetron.
• Lungs: It is unknown whether Palozest 0.25mg Injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking Palozest 0.25mg Injection because Palonosetron contains a small amount of alcohol which may cause dizziness and impair your concentration.
• Pregnancy: It is unknown whether Palozest 0.25mg Injection can be administered during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.